Clinical trial
Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
NCT00227227 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00227227 |
|---|---|
| Title | Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis |
| Official title | Observational Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Ankylosing Spondylitis |
| Enrollment | 750 |
| Start date | May 1, 2004 |
| Completion | Jun 1, 2007 |
| First posted | Sep 27, 2005 |
| Last update posted | Dec 10, 2007 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: